Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, an... Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. Show more
NEW YORK and MELBOURNE, Australia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company developing innovative...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.08 | -4.41988950276 | 1.81 | 2.08 | 1.7128 | 13963 | 1.8827256 | CS |
4 | -0.23 | -11.7346938776 | 1.96 | 2.08 | 1.6 | 17329 | 1.80072655 | CS |
12 | -0.32 | -15.6097560976 | 2.05 | 3.1199 | 1.52 | 30643 | 2.15690641 | CS |
26 | -1.62 | -48.3582089552 | 3.35 | 3.55 | 1.5 | 30218 | 2.15912835 | CS |
52 | -1.98 | -53.3692722372 | 3.71 | 8.4697 | 1.5 | 101017 | 5.00461932 | CS |
156 | -9.27 | -84.2727272727 | 11 | 90 | 0.8 | 75058 | 6.77678924 | CS |
260 | -9.27 | -84.2727272727 | 11 | 90 | 0.8 | 75058 | 6.77678924 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales